No Data
No Data
Global Bovine Respiratory Disease Treatment Strategic Business Report 2024-2030 Featuring Bayer, Bimeda, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Merck, Vetoquinol, Virbac, & Zoetis
Breakthroughs in AI Chips and Image Recognition Propel Market Growth and Business Enhancements
USA News Group – The race to improve artificial intelligence (AI) is accelerating at breakneck speed, with China recently unveiling a new...
CEVA Inc (CEVA) Q1 2024 Earnings: Misses Revenue and Earnings Expectations Amid Challenges
CEVA Is Maintained at Neutral by Roth MKM
CEVA Is Maintained at Neutral by Roth MKM
Express News | Roth MKM Maintains Neutral on CEVA, Lowers Price Target to $20
CEVA Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 0.4% Roth MKM $25 → $20 Maintains Neutral 02/13/2024 40.56% Rosenblatt → $28 Reiterates Buy → B
Zaki Azhari : Are we gonna be ok?